Pro Nephro AKI (NGAL) is now FDA-Cleared READ MORE

Investor Contacts

Other Ways to Connect

To receive investor announcements, please subscribe below.

Investor Relations

Niels Høy Nielsen, BioPorto A/S

BioPorto A/S Headquarters

Tuborg Havnevej 15
2900 Hellerup
Denmark

Contact Investor Relations

Name(Required)

First Last

Email(Required)

Phone

Country(Required)

States(Required)

Message(Required)

Comments

This field is for validation purposes and should be left unchanged.